A new FGFR inhibitor disrupts the TGF‐β1‐induced fibrotic process

Pulmonary fibrosis (PF) is chronic and irreversible damage to the lung characterized by fibroblast activation and matrix deposition. Although recently approved novel anti‐fibrotic agents can improve the lung function and survival of patients with PF, the overall outcomes remain poor. In this study,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Kim, Mi‐Hyoung, Jung, Seung‐Youn, Song, Kyung‐Hee, Park, Jeong‐In, Ahn, Jiyeon, Kim, Eun‐Ho, Park, Jong Kuk, Hwang, Sang‐Gu, Woo, Hee‐Jong, Song, Jie‐Young
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933341/
https://ncbi.nlm.nih.gov/pubmed/31692229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14793
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars